BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30653790)

  • 1. Using the diffusion of innovations model to guide participant engagement in the genomics era.
    Lewis KL; Facio FM; Berrios CD
    J Genet Couns; 2019 Apr; 28(2):419-427. PubMed ID: 30653790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The business of genomic testing: a survey of early adopters.
    Crawford JM; Bry L; Pfeifer J; Caughron SK; Black-Schaffer S; Kant JA; Kaufman JH
    Genet Med; 2014 Dec; 16(12):954-61. PubMed ID: 25010053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and Annotation of Whole-Genome or Whole-Exome Sequencing Derived Variants for Clinical Diagnosis.
    Worthey EA
    Curr Protoc Hum Genet; 2017 Oct; 95():9.24.1-9.24.28. PubMed ID: 29044471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling Genetic Counseling in the Genomics Era.
    Amendola LM; Golden-Grant K; Scollon S
    Annu Rev Genomics Hum Genet; 2021 Aug; 22():339-355. PubMed ID: 33722076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network.
    Schuster AL; Crossnohere NL; Bachini M; Blair CK; Carpten JD; Claus EB; Colditz GA; Ding L; Drake BF; Fields RC; Janeway KA; Kwan BM; Lenz HJ; Ma Q; Mishra SI; Paskett ED; Rebbeck TR; Ricker C; Stern MC; Sussman AL; Tiner JC; Trent JM; Verhaak RG; Wagle N; Willman C; Bridges JF;
    Cancer Epidemiol Biomarkers Prev; 2023 Apr; 32(4):487-495. PubMed ID: 36791345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion of innovations: a guiding framework for public health.
    Iqbal M; Zahidie A
    Scand J Public Health; 2022 Jul; 50(5):533-537. PubMed ID: 34058897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease.
    Buchanan J; Blair E; Thomson KL; Ormondroyd E; Watkins H; Taylor JC; Wordsworth S
    Eur J Hum Genet; 2019 Nov; 27(11):1639-1648. PubMed ID: 31186546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic counseling for consumer-driven whole exome and whole genome sequencing: A commentary on early experiences.
    Schmidt JL; Maas R; Altmeyer SR
    J Genet Couns; 2019 Apr; 28(2):449-455. PubMed ID: 30861266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical implementation of copy number detection in the age of next-generation sequencing.
    Hehir-Kwa JY; Tops BBJ; Kemmeren P
    Expert Rev Mol Diagn; 2018 Oct; 18(10):907-915. PubMed ID: 30221560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public interest in whole genome sequencing and information needs: an online survey study.
    Etchegary H; Wilson B; Rahman P; Simmonds C; Pullman D
    Per Med; 2020 Jul; 17(4):283-293. PubMed ID: 32589098
    [No Abstract]   [Full Text] [Related]  

  • 12. Using the Diffusion of Innovations theory to understand the uptake of genetics in nursing practice: identifying the characteristics of genetic nurse adopters.
    Andrews V; Tonkin E; Lancastle D; Kirk M
    J Adv Nurs; 2014 Apr; 70(4):878-93. PubMed ID: 24102681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
    Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
    Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early adoption of BRCA1/2 testing: who and why.
    Armstrong K; Weiner J; Weber B; Asch DA
    Genet Med; 2003; 5(2):92-8. PubMed ID: 12644778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Framework for Introducing Global Health Innovations to the US.
    Shin SY; Lapinski MK; Hussain SA; Rumbold Y; Osoro R; Shell D; Dearing JW
    Ann Glob Health; 2022; 88(1):67. PubMed ID: 36043039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.
    Elfatih A; Mohammed I; Abdelrahman D; Mifsud B
    Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing genomic medicine in pathology.
    Williams ES; Hegde M
    Adv Anat Pathol; 2013 Jul; 20(4):238-44. PubMed ID: 23752086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adapting a conceptual framework to engage diverse stakeholders in genomic/precision medicine research.
    Watson KS; Cohn EG; Fair A; Menon U; Szalacha LA; Carpenter SM; Wilkins CH
    Health Expect; 2022 Aug; 25(4):1478-1485. PubMed ID: 35353945
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.